Condition: CIDP · Sponsor: University of Ulm
This is a randomized controlled study evaluating safety and efficacy of repeated immunoadsorption versus immunoglobulins in steroid-refractory Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
This description comes directly from the study's public registry record.
Johannes Dorst, Prof · +49 731 177 5285 · johannes.dorst@uni-ulm.de
Always discuss trial participation with your own doctor first.
| Department of Neurology, University of Ulm | Ulm, Baden-Wurttemberg, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04881682